Electrical properties of prostatic tissues: I. Single frequency admittivity properties
- PMID: 19683745
- PMCID: PMC2810557
- DOI: 10.1016/j.juro.2009.06.007
Electrical properties of prostatic tissues: I. Single frequency admittivity properties
Abstract
Purpose: Electrical properties of the prostate may provide sufficient contrast for distinguishing malignant and benign formations in the gland. We evaluated how well these electrical properties discriminate cancer from noncancer tissues in the prostate.
Materials and methods: Electrical admittivity (conductivity and permittivity) was recorded at 31 discrete frequencies of 0.1 to 100 kHz from each of 50 ex vivo human prostates. A specifically designed admittivity probe was used to gauge these electrical properties from sectioned prostate specimens. The specific tissue area probed was marked to provide precise colocalization between tissue histological assessment and recorded admittivity spectra.
Results: Adenocarcinoma, benign prostatic hyperplasia, nonhyperplastic glandular tissue and stromal tissue were the primary tissue types probed. Mean cancer conductivity was significantly less than that of glandular and stromal tissues at all frequencies (p <0.05), while mean cancer permittivity was significantly greater than that of all benign tissues at 100 kHz (p <0.0001). ROC curves showed that permittivity at 100 kHz was optimal for discriminating cancer from all benign tissues. This parameter had 77% specificity at 70% sensitivity and an ROC AUC of 0.798.
Conclusions: The contrast in electrical admittivity properties of different prostate tissues shows promise for distinguishing cancer from benign tissues. Sensitivity and specificity exceed those reported for current prostate specific antigen screening practices at low prostate specific antigen, making this an attractive addition to the clinical armamentarium for identifying prostate cancer.
Figures





References
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71. - PubMed
-
- Linn MM, Ball RA, Maradiegue A. Prostate-specific antigen screening: friend or foe? Urol Nurs. 2007;27:481. - PubMed
-
- Roberts RO, Bergstralh EJ, Peterson NR, et al. Positive and negative biopsies in the pre-prostate specific antigen and prostate specific antigen eras, 1980 to 1997. J Urol. 2000;163:1471. - PubMed
-
- Schwartz MJ, Hwang DH, Hung AJ, et al. Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy. Cancer. 2008;112:1718. - PubMed
-
- Savage L. Is an improved PSA screening test in sight? J Natl Cancer Inst. 2007;99:1503. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical